Cargando…

Does Preoperative Low HbA1c Predict Esophageal Cancer Outcomes?

Background: Although several reports have shown that diabetes is a poor prognostic factor for esophageal cancer, no reports assessed prognostic impact of hemoglobin A1c (HbA1c) in the patients with esophageal cancer. Therefore, we evaluated the prognostic significance of HbA1c in patients with esoph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kochi, Ryosuke, Suzuki, Takashi, Yajima, Satoshi, Oshima, Yoko, Ito, Masaaki, Funahashi, Kimihiko, Shimada, Hideaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435137/ https://www.ncbi.nlm.nih.gov/pubmed/31666442 http://dx.doi.org/10.5761/atcs.oa.19-00238

Ejemplares similares

Preoperative Low Serum Calcium Levels Predict Poor Prognosis for Patients with Esophageal Cancer
por: Shiratori, Fumiaki, et al.
Publicado: (2021)

Is High Score of Preoperative Lactate Dehydrogenase to Albumin Ratio Predicting Poor Survivals in Esophageal Carcinoma Patients?
por: Shiratori, Fumiaki, et al.
Publicado: (2023)

High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer
por: Ito, Masaaki, et al.
Publicado: (2019)

Randomized Phase II Study to Comparing Docetaxel/Nedaplatin versus Docetaxel for 5-Fluorouracil/Cisplatin Resistant Esophageal Squamous Cell Carcinoma
por: Yajima, Satoshi, et al.
Publicado: (2021)

Diagnostic impact of high serum midkine level in patients with gastric cancer
por: Ito, Masaaki, et al.
Publicado: (2019)

Is high serum programmed death ligand 1 level a risk factor for poor survival in patients with gastric cancer?
por: Ito, Masaaki, et al.
Publicado: (2018)

Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer
por: Ito, Masaaki, et al.
Publicado: (2021)

Neck Dissection for Thoracic Esophageal Squamous Cell Carcinoma
por: Yajima, Satoshi, et al.
Publicado: (2012)

Serum WT1-271 IgM antibody as a novel diagnostic marker for Gastric Cancer
por: Ito, Masaaki, et al.
Publicado: (2022)

Prevalence of serum galectin-1 autoantibodies in seven types of cancer: A potential biomarker
por: Nanami, Tatsuki, et al.
Publicado: (2021)

The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma
por: Ito, Masaaki, et al.
Publicado: (2023)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

Standardization of the HbA(2) Assay
por: Paleari, Renata, et al.
Publicado: (2018)

A Case of Dermatomyositis Along with Esophageal Cancer and Screening of Serum Transcriptional Intermediary Factor 1 Gamma Antibodies in Various Cancer Patients
por: Sumazaki, Makoto, et al.
Publicado: (2020)

Does cancer risk increase with HbA(1c), independent of diabetes?
por: de Beer, J C, et al.
Publicado: (2014)

A Two-Step Screening, Measurement of HbA1c in Association with FPG, May Be Useful in Predicting Diabetes
por: Nomura, Kyoko, et al.
Publicado: (2012)

Preoperative CRP(−)/CEA(−)/CA19-9(−)/non-T4 in Stage III Colorectal Cancer Is Favorable Risk for Recurrence
por: Ushigome, Mitsunori, et al.
Publicado: (2022)

In-House Algorithm for Reporting Discrepant HbA1c Result and Troubleshooting a Case of False Low HbA1c
por: Pant, Vivek, et al.
Publicado: (2021)

HbA(1c): The lower the better?
por: Araki, Eiichi, et al.
Publicado: (2011)

Low HbA2 Level in β-Thalassemia Trait
por: ÖZSOYLU, Şinasi
Publicado: (2013)

Very low HbA1C, is it a problem?
por: Joob, Beuy, et al.
Publicado: (2018)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Haemoglobin J-Baltimore can be detected by HbA(1c) electropherogram but with underestimated HbA(1c) value
por: Brunel, Valéry, et al.
Publicado: (2016)

Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
por: Feng, Xiaojing, et al.
Publicado: (2021)

Change in HbA(1c) over 3 years does not improve the prediction of cardiovascular disease over and above HbA(1c) measured at a single time point
por: Chamnan, P., et al.
Publicado: (2013)

Point-of-Care Measurements of HbA(1c): Simplicity Does Not Mean Laxity With Controls
por: Leca, Viviane, et al.
Publicado: (2012)

Does the SDMQ-9 Predict Changes in HbA1c Levels? An Ecuadorian Cohort
por: Farfán Bajaña, María José, et al.
Publicado: (2022)

Hb H Interference on Measurement Of HbA1c With Ion-Exchange HPLC
por: Agilli, Mehmet, et al.
Publicado: (2013)

Drugs affecting HbA1c levels
por: Unnikrishnan, Ranjit, et al.
Publicado: (2012)

Current Status of HbA1c Biosensors
por: Lin, Hua, et al.
Publicado: (2017)

Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements
por: Nasir, Nadzimah Mohd, et al.
Publicado: (2010)

Estimation of mean erythrocyte age using HbA1c or HbA1c/glycated albumin for evaluation of anemia severity
por: Koga, Masafumi, et al.
Publicado: (2023)

Novel cancer‐specific epidermal growth factor receptor antibody obtained from the serum of esophageal cancer patients with long‐term survival
por: Takagi‐Maeda, Sayaka, et al.
Publicado: (2022)

Preoperative HbA1c and Blood Glucose Measurements in Diabetes Mellitus before Oral Surgery and Implantology Treatments
por: Végh, Dániel, et al.
Publicado: (2023)

Differential Thermal Stability and Oxidative Vulnerability of the Hemoglobin Variants, HbA(2) and HbE
por: Chakrabarti, Abhijit, et al.
Publicado: (2013)

Significantly High HbA(1c) in Diabetic Patient with Hb J: Case Report
por: Wan Nik, Wan Nor Fazila Hafizan, et al.
Publicado: (2022)

HbA(1c) measurement and relationship to incident stroke
por: Robson, R., et al.
Publicado: (2016)

Engineering of the endogenous HBD promoter increases HbA2
por: Boontanrart, Mandy Y, et al.
Publicado: (2023)

Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes
por: Matsutani, Daisuke, et al.
Publicado: (2018)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o6uucveh61qqo9m97kg1hu5bjk